Protein inhibitor of activated signal transducer and activator of transcription 1 interacts with the N-terminal domain of mineralocorticoid receptor and represses its transcriptional activity: implication of small ubiquitin-related modifier 1 modification - PubMed (original) (raw)
. 2003 Dec;17(12):2529-42.
doi: 10.1210/me.2003-0299. Epub 2003 Sep 18.
Affiliations
- PMID: 14500761
- DOI: 10.1210/me.2003-0299
Protein inhibitor of activated signal transducer and activator of transcription 1 interacts with the N-terminal domain of mineralocorticoid receptor and represses its transcriptional activity: implication of small ubiquitin-related modifier 1 modification
Laurent Pascual-Le Tallec et al. Mol Endocrinol. 2003 Dec.
Abstract
Molecular mechanisms underlying mineralocorticoid receptor (MR)-mediated gene expression are not fully understood but seem to largely depend upon interactions with specific coregulators. To identify novel human MR (hMR) molecular partners, yeast two-hybrid screenings performed using the N-terminal domain as bait, allowed us to isolate protein inhibitor of activated signal transducer and activator of transcription (PIAS)1 and PIASxbeta, described as SUMO (small ubiquitin-related modifier) E3-ligases. Specific interaction between PIAS1 and hMR was confirmed by glutathione-S-transferase pull-down experiments and N-terminal subdomains responsible for physical contacts were delineated. Transient transfections demonstrated that PIAS1 is a corepressor of aldosterone-activated MR transactivation but has no significant effect on human glucocorticoid receptor transactivation. The agonist or antagonist nature of the bound ligand also determines PIAS1 corepressive action. We provided evidence that PIAS1 conjugated SUMO-1 to hMR both in vitro and in vivo. Deciphering the unique sumoylation pattern of hMR, which possesses five consensus SUMO-1 binding sites, by combinatorial lysine substitutions, revealed a major impact of sumoylation on hMR properties. Using a murine mammary tumor virus promoter, PIAS1 action was independent of sumoylation whereas with glucocorticoid response element promoter, PIAS1 corepressive action depended on hMR sumoylation status. Taken together, our results identify a novel function for PIAS1 which interacts with the N-terminal domain of hMR and represses its ligand-dependent transcriptional activity, at least in part, through SUMO modifications.
Similar articles
- The manifold actions of the protein inhibitor of activated STAT proteins on the transcriptional activity of mineralocorticoid and glucocorticoid receptors in neural cells.
Tirard M, Jasbinsek J, Almeida OF, Michaelidis TM. Tirard M, et al. J Mol Endocrinol. 2004 Jun;32(3):825-41. doi: 10.1677/jme.0.0320825. J Mol Endocrinol. 2004. PMID: 15171715 - Protein inhibitor of activated STAT-1 (signal transducer and activator of transcription-1) is a nuclear receptor coregulator expressed in human testis.
Tan J, Hall SH, Hamil KG, Grossman G, Petrusz P, Liao J, Shuai K, French FS. Tan J, et al. Mol Endocrinol. 2000 Jan;14(1):14-26. doi: 10.1210/mend.14.1.0408. Mol Endocrinol. 2000. PMID: 10628744 - The transcriptional repression activity of KyoT2 on the Notch/RBP-J pathway is regulated by PIAS1-catalyzed SUMOylation.
Wang J, Qin H, Liang J, Zhu Y, Liang L, Zheng M, Han H. Wang J, et al. J Mol Biol. 2007 Jun 29;370(1):27-38. doi: 10.1016/j.jmb.2007.04.010. Epub 2007 Apr 12. J Mol Biol. 2007. PMID: 17509614 - PIAS proteins as regulators of small ubiquitin-related modifier (SUMO) modifications and transcription.
Palvimo JJ. Palvimo JJ. Biochem Soc Trans. 2007 Dec;35(Pt 6):1405-8. doi: 10.1042/BST0351405. Biochem Soc Trans. 2007. PMID: 18031232 Review. - Expression and function of the human mineralocorticoid receptor: lessons from transgenic mouse models.
Le Menuet D, Viengchareun S, Muffat-Joly M, Zennaro MC, Lombès M. Le Menuet D, et al. Mol Cell Endocrinol. 2004 Mar 31;217(1-2):127-36. doi: 10.1016/j.mce.2003.10.045. Mol Cell Endocrinol. 2004. PMID: 15134811 Review.
Cited by
- Importance of Micromilieu for Pathophysiologic Mineralocorticoid Receptor Activity-When the Mineralocorticoid Receptor Resides in the Wrong Neighborhood.
Griesler B, Schuelke C, Uhlig C, Gadasheva Y, Grossmann C. Griesler B, et al. Int J Mol Sci. 2022 Oct 20;23(20):12592. doi: 10.3390/ijms232012592. Int J Mol Sci. 2022. PMID: 36293446 Free PMC article. Review. - Functional genomics study of protein inhibitor of activated STAT1 in mouse hippocampal neuronal cells revealed by RNA sequencing.
He K, Zhang J, Liu J, Cui Y, Liu LG, Ye S, Ban Q, Pan R, Liu D. He K, et al. Aging (Albany NY). 2021 Mar 24;13(6):9011-9027. doi: 10.18632/aging.202749. Epub 2021 Mar 24. Aging (Albany NY). 2021. PMID: 33759814 Free PMC article. - Structure and function of steroid receptor AF1 transactivation domains: induction of active conformations.
Lavery DN, McEwan IJ. Lavery DN, et al. Biochem J. 2005 Nov 1;391(Pt 3):449-64. doi: 10.1042/BJ20050872. Biochem J. 2005. PMID: 16238547 Free PMC article. Review. - Normosmic congenital hypogonadotropic hypogonadism due to TAC3/TACR3 mutations: characterization of neuroendocrine phenotypes and novel mutations.
Francou B, Bouligand J, Voican A, Amazit L, Trabado S, Fagart J, Meduri G, Brailly-Tabard S, Chanson P, Lecomte P, Guiochon-Mantel A, Young J. Francou B, et al. PLoS One. 2011;6(10):e25614. doi: 10.1371/journal.pone.0025614. Epub 2011 Oct 21. PLoS One. 2011. PMID: 22031817 Free PMC article. - Control of progesterone receptor transcriptional synergy by SUMOylation and deSUMOylation.
Abdel-Hafiz HA, Horwitz KB. Abdel-Hafiz HA, et al. BMC Mol Biol. 2012 Mar 22;13:10. doi: 10.1186/1471-2199-13-10. BMC Mol Biol. 2012. PMID: 22439847 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials